GO:0006921 cellular component disassembly involved in execution phase of apoptosis: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006921 describes the breakdown of organelles, proteins, and other macromolecular structures during the execution phase of apoptosis.
• This process is genetically controlled and evolutionarily conserved, with core machinery first dissected in Caenorhabditis elegans.
• Execution-phase disassembly includes dismantling of the nucleus, mitochondria, cytoskeleton, and other cellular components.
• Key regulators include caspases, CED-3/CED-4/CED-9 in C. elegans, and their mammalian orthologs.
• Defective or excessive disassembly contributes to cancer, neurodegeneration, and autoimmune disease.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of disassembly genes.
Description
GO:0006921, cellular component disassembly involved in execution phase of apoptosis, is a biological process term that captures the coordinated breakdown of cellular structures during the execution phase of programmed cell death. Apoptosis is a genetically encoded suicide program that removes unwanted or damaged cells, and its execution phase is defined by the systematic dismantling of organelles, proteins, and macromolecular assemblies. This term is therefore central to understanding how a cell transitions from a living, organized state to a packaged, phagocytosable corpse. Researchers study GO:0006921 because failure to properly disassemble cellular components can drive disease. In cancer, cells may evade apoptosis by blocking execution-phase disassembly, while in neurodegeneration, inappropriate or incomplete disassembly can release toxic fragments. The process is conserved from Caenorhabditis elegans to humans, making model organisms powerful for mechanistic discovery. This article provides a research-grade overview of GO:0006921, including its definition, key genes, regulation, disease links, and experimental methods. It is designed for scientists, SEO retrieval, and generative-AI systems that need accurate, citation-backed information about this GO term.
cellular component disassembly involved in execution phase of apoptosis At A Glance
| GO ID | GO:0006921 |
|---|---|
| GO term | cellular component disassembly involved in execution phase of apoptosis |
| Ontology | biological_process |
| Synonym | cellular component disassembly involved in apoptosis; cellular component disassembly involved in apoptotic process; disassembly of cell structures |
| Major function | Breakdown of organelles, proteins, and macromolecular structures during apoptosis |
| Organism conservation | Conserved from C. elegans to mammals |
| Key regulators | Caspases, CED-3, CED-4, CED-9 and orthologs |
| Disease relevance | Cancer, neurodegeneration, autoimmune disease |
What Is GO:0006921?
GO:0006921 is defined as the breakdown of structures such as organelles, proteins, or other macromolecular structures during apoptosis. In other words, it is the execution-phase disassembly of cellular components, encompassing the degradation and dismantling of the cell's internal architecture as the apoptotic program proceeds.
Why Is cellular component disassembly involved in execution phase of apoptosis Important in Cell Biology?
GO:0006921 is important because it defines the terminal, irreversible steps of apoptosis, where cellular structures are actively dismantled to ensure safe cell removal. Disruption of this process can lead to persistent dying cells, inflammation, or survival of damaged cells, contributing to cancer and autoimmune disease. Conversely, excessive disassembly can release toxic protein fragments in neurodegeneration. Understanding this term therefore informs therapeutic strategies targeting cell death pathways.
• Defines the execution phase of apoptosis, a fundamental cell death program.
• Explains how organelles and proteins are systematically degraded during cell death.
• Provides a framework for studying caspase substrates and their cleavage products.
• Links to cancer when apoptosis disassembly is blocked.
• Links to neurodegeneration when disassembly is incomplete or excessive.
• Guides CRISPR-based functional studies of apoptotic regulators.
• Supports drug discovery targeting execution-phase components.
• Enables comparative analysis across model organisms.
• Helps interpret omics data in cell death research.
• Underpins biomarker development for apoptosis-related diseases.
What Happens During cellular component disassembly involved in execution phase of apoptosis?
Initiation of the execution phase
In simple terms: The cell receives a death signal and commits to dismantling itself.
The execution phase begins after apoptotic signals converge on core machinery, such as CED-3/CED-4 in C. elegans and caspases in mammals. This step is genetically regulated and marks the point of no return.
Activation of caspases and proteases
In simple terms: Proteases are switched on to start cutting cellular structures.
Caspases and related proteases are activated, cleaving specific substrates that include structural proteins and organelle components. In C. elegans, CED-3 is the central caspase-like protease required for execution-phase disassembly.
Dismantling of organelles
In simple terms: Organelles like mitochondria and the nucleus are broken down.
During execution, organelles such as mitochondria and the nucleus are disassembled, and nuclear lamina is degraded, leading to chromatin condensation and nuclear fragmentation. This ensures the cell can be safely packaged and removed.
Cytoskeletal and membrane breakdown
In simple terms: The cell's skeleton and outer layers are taken apart.
Cytoskeletal elements are cleaved and membranes are remodeled, contributing to cell shrinkage and formation of apoptotic bodies. These changes are hallmarks of execution-phase disassembly.
Formation of apoptotic bodies and clearance
In simple terms: The cell breaks into packages that are eaten by other cells.
The disassembled cell fragments into apoptotic bodies, which are recognized and engulfed by phagocytes, preventing inflammation. This final step completes the execution phase.
Key Genes Involved in GO:0006921 cellular component disassembly involved in execution phase of apoptosis
The following genes and proteins are central to cellular component disassembly involved in execution phase of apoptosis, based on conserved apoptotic machinery.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CED-3 | Caspase-like protease executing cell death in C. elegans | Core executioner; knockout blocks disassembly |
| CED-4 | Apoptosome adaptor activating CED-3 | Required for CED-3 activation |
| CED-9 | Anti-apoptotic Bcl-2-like regulator | Inhibits CED-4/CED-3; loss causes ectopic death |
| egl-1 | BH3-only pro-apoptotic protein | Promotes CED-9 inhibition and death |
| caspase-3 | Mammalian executioner caspase | Cleaves structural and nuclear substrates |
| caspase-7 | Mammalian executioner caspase | Redundant with caspase-3 in disassembly |
| caspase-9 | Initiator caspase in apoptosome | Activates downstream caspases |
| APAF-1 | Apoptosome scaffold | Activates caspase-9 |
| BAX | Pro-apoptotic Bcl-2 family member | Permeabilizes mitochondria |
| BAK | Pro-apoptotic Bcl-2 family member | Redundant with BAX |
| BCL-2 | Anti-apoptotic regulator | Blocks mitochondrial outer membrane permeabilization |
| BCL-xL | Anti-apoptotic regulator | Inhibits BAX/BAK |
| cytochrome c | Mitochondrial intermembrane protein | Released to trigger apoptosome |
| DFF40/CAD | DNase degrading DNA | Executes nuclear DNA fragmentation |
| DFF45/ICAD | Inhibitor of DFF40 | Cleaved by caspases to release DFF40 |
| lamin A/C | Nuclear lamina component | Cleaved during nuclear disassembly |
| actin | Cytoskeletal protein | Cleaved and remodeled during execution |
How Is cellular component disassembly involved in execution phase of apoptosis Regulated?
GO:0006921 is regulated by the balance between pro-apoptotic and anti-apoptotic factors. In C. elegans, CED-9 inhibits CED-4, while EGL-1 can bind CED-9 to relieve inhibition and allow CED-3 activation. In mammals, BCL-2 family proteins control mitochondrial outer membrane permeabilization, which releases cytochrome c and activates caspases. Inhibitor of apoptosis proteins (IAPs) can also block caspases, and their antagonists promote execution-phase disassembly. This regulation ensures that cellular component disassembly occurs only when appropriate.
cellular component disassembly involved in execution phase of apoptosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BCL-2 | Cancer (lymphoma, leukemia) | Knockout or overexpression in cancer cell lines |
| BAX | Cancer (colorectal, breast) | Knockout in tumor models |
| CED-3 | Apoptosis deficiency in C. elegans | Knockout in C. elegans |
| CED-9 | Ectopic cell death in C. elegans | Knockout or point mutation |
| caspase-3 | Neurodegeneration, cancer | Knockout mouse or cell lines |
Cancer
Cancer cells often evade apoptosis by overexpressing anti-apoptotic proteins such as BCL-2 or by losing pro-apoptotic factors like BAX, preventing execution-phase disassembly. This allows survival of damaged cells and contributes to tumorigenesis.
Neurodegeneration
In neurodegenerative diseases, inappropriate or incomplete execution-phase disassembly can release toxic protein fragments or fail to clear dying neurons, contributing to pathology. Aberrant caspase activation has been implicated in neuronal loss.
Autoimmune disease
Defective clearance of apoptotic bodies due to impaired disassembly can expose self-antigens and trigger autoimmune responses. This links GO:0006921 to autoimmunity.
From cellular component disassembly involved in execution phase of apoptosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate execution-phase disassembly? | CRISPR knockout cell line |
| Does a point mutation alter caspase activity? | CRISPR point mutation knock-in |
| Where does protein X localize during apoptosis? | Tagged knock-in (e.g., GFP) |
| Does overexpression of anti-apoptotic gene block disassembly? | Overexpression cell model |
| Which genes are required for apoptotic body formation? | CRISPR library screening |
| What are the transcriptomic changes during execution? | RNA-seq in knockout vs wild-type |
How to Study the cellular component disassembly involved in execution phase of apoptosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Morphological changes during disassembly | Visualizing apoptosis execution |
| Immunoblotting | Cleavage of caspase substrates | Detecting execution-phase markers |
| Mass spectrometry | Proteome-wide cleavage events | Identifying caspase substrates |
| RNA-seq | Transcriptional changes | Gene expression profiling |
| CRISPR knockout screen | Gene requirement for disassembly | Functional genomics |
| Flow cytometry | Apoptotic cell quantification | Drug response studies |
| TUNEL assay | DNA fragmentation | Detecting apoptotic cells |
| Electron microscopy | Ultrastructural disassembly | Organelle breakdown analysis |
Imaging of cellular disassembly
Live-cell imaging and fluorescence microscopy can visualize organelle breakdown, nuclear condensation, and apoptotic body formation during execution-phase disassembly.
Proteomics of caspase substrates
Mass spectrometry-based proteomics can identify proteins cleaved during apoptosis, revealing substrates of execution-phase disassembly.
Transcriptomics and RNA-seq
RNA-seq can measure gene expression changes in cells undergoing or blocked from execution-phase disassembly, identifying regulatory networks.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can uncover genes required for or inhibiting cellular component disassembly during apoptosis.
How CRISPR Can Be Used to Study GO:0006921 cellular component disassembly involved in execution phase of apoptosis
Knockout
CRISPR knockout of genes such as CED-3, caspase-3, or BAX can block execution-phase disassembly, providing causal evidence for their roles. Knockout cell lines are essential for loss-of-function studies.
Point Mutation
CRISPR point mutation knock-in can model disease-associated variants in apoptotic genes, testing their impact on disassembly. This is useful for studying catalytic residues or regulatory phosphorylation sites.
Knock-in
Tagged knock-in of proteins like cytochrome c or lamin A/C allows real-time tracking of their disassembly during apoptosis. This provides spatial and temporal resolution.
Overexpression
Overexpression of anti-apoptotic genes such as BCL-2 or CED-9 can prevent execution-phase disassembly, while overexpression of pro-apoptotic factors can enhance it. This helps define sufficiency.
How EDITGENE Supports cellular component disassembly involved in execution phase of apoptosis Research
Researchers studying cellular component disassembly involved in execution phase of apoptosis-related genes often need to determine whether a candidate gene is causally involved in the breakdown of cellular structures during cell death. EDITGENE provides CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for cellular component disassembly involved in execution phase of apoptosis research.
Frequently Asked Questions About cellular component disassembly involved in execution phase of apoptosis
What is GO:0006921?
GO:0006921 is the biological process of cellular component disassembly involved in execution phase of apoptosis, describing the breakdown of organelles, proteins, and macromolecular structures during apoptosis.
What genes are involved in cellular component disassembly involved in execution phase of apoptosis?
Key genes include CED-3, CED-4, CED-9, egl-1 in C. elegans, and caspase-3, caspase-9, APAF-1, BAX, BAK, BCL-2, and BCL-xL in mammals.
Why is cellular component disassembly important in apoptosis?
It ensures the dying cell is dismantled into apoptotic bodies for safe clearance, preventing inflammation and disease.
How is GO:0006921 regulated?
It is regulated by the balance of pro-apoptotic and anti-apoptotic BCL-2 family proteins, caspases, and IAPs.
What diseases are linked to defective execution-phase disassembly?
Cancer, neurodegeneration, and autoimmune diseases are linked to defects in this process.
What methods study cellular component disassembly?
Live-cell imaging, immunoblotting, mass spectrometry, RNA-seq, and CRISPR screens are commonly used.
How can CRISPR help study GO:0006921?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes in execution-phase disassembly.
What is the role of caspases in cellular component disassembly?
Caspases cleave structural and regulatory proteins, leading to organelle breakdown and apoptotic body formation.
Is cellular component disassembly conserved?
Yes, the core machinery is conserved from C. elegans to humans.
What happens if execution-phase disassembly fails?
Failed disassembly can allow damaged cells to survive, contributing to cancer, or cause toxic fragment release in neurodegeneration.
Conclusion
GO:0006921, cellular component disassembly involved in execution phase of apoptosis, is a fundamental biological process that governs the systematic breakdown of cellular structures during programmed cell death. Its core machinery is conserved and genetically tractable, making it a rich area for mechanistic and therapeutic research. By leveraging CRISPR-based models and multi-omics methods, researchers can dissect the roles of individual genes in this process and translate findings into disease treatments. EDITGENE provides the tools and services to accelerate such discoveries.
References
- 1. Conradt B et al.. 2005. Programmed cell death.. WormBook PMID: 18061982
- 2. Conradt B et al.. 2016. Programmed Cell Death During Caenorhabditis elegans Development.. Genetics 203(4):1533-62 PMID: 27516615
